Israeli drug effective in combating fatty liver disease - new research
The news of the research comes as the disease is at the forefront of conversation, as patients are more likely to develop acute cases of COVID-19.
Allen Baharaff, Galmed's CEO(photo credit: ARKADI RASKIN)